Pharmaceutical - Diabetes, Healthcare


Current filters:


Popular Filters

Patient access to novel non-insulin treatments is sub-optimal in China


With respect to the treatment of type 2 diabetes in China, patient access to premium-priced agents is…

AstraZenecaByettaChinaDiabetesHealthcareJanuviaMarkets & MarketingMerck & CoPharmaceutical

UK diabetes patients being denied vital prescriptions for testing strips


Patients in Britain with diabetes are missing out on vital prescriptions that let them keep tabs on their…


Large increase seen in insulin use, out-of-pocket costs for type 2 diabetes


Largely attributable to the widespread adoption of insulin analogs, use of insulin among patients with…


Quebec first province to add Victoza to the drug benefit formulary

Quebec first province to add Victoza to the drug benefit formulary


The Canadian subsidiary of Danish diabetes care giant Novo Nordisk says that the Quebec government has…

CanadaDiabetesFinancialHealthcareNovo NordiskPharmaceuticalVictoza

Ukraine MoH signs “understanding” with insulin producers


On March 19, Oleg Musiy, the Minister of Health in Ukraine, signed the memorandum of understanding with…

DiabetesEastern EuropeHealthcarePharmaceuticalPricingUkraine

Latest Australian PBS Listings include medicines for children

Latest Australian PBS Listings include medicines for children


Ten new medicines to treat a range of illnesses from rare forms of cancer to skin conditions will be…


Australian patients benefit from PBS changes; cancer research


New medicines for glaucoma, diabetes and advanced soft tissue sarcoma have been approved for listing…


Novo Nordisk launches diabetes collaboration focused on integrated care with London partners

Novo Nordisk launches diabetes collaboration focused on integrated care with London partners


A unique collaboration between leading London hospitals and Danish insulin giant Novo Nordisk (NOV: N)…

DiabetesHealthcareNovo NordiskPharmaceuticalUK

Pharma appeals to Ukraine Health Ministry on insulin supply problems

Pharma appeals to Ukraine Health Ministry on insulin supply problems


The Association of Pharmaceutical Research and Development and the American Chamber of Commerce in Ukraine…

DiabetesEastern EuropeHealthcarePharmaceuticalPricingUkraine

Cardiovascular risk a concern when prescribing diabetes treatments, survey finds


Boehringer Ingelheim and Eli Lilly (NYSE: LLY) revealed that 79% of nearly 800 physicians in four Asian…

Asia-PacificBoehringer IngelheimDiabetesEli LillyHealthcarePharmaceuticalResearch

$200+ billion annual opportunity in USA from using medicines more responsibly, IMS finds


Avoidable costs of more than $200 billion are incurred each year in the US health care system as a result…

Antibiotics and Infectious diseasesDiabetesFinancialGenericsHealthcareNorth AmericaPharmaceutical

Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review


Global insulin market leader Novo Nordisk (NOV: N) of Denmark revealed this morning that its Ryzodeg…

Asia-PacificDegludecDiabetesGlobalHealthcareNovo NordiskPharmaceuticalPricingRegulationRyzodegTresiba

In England, diabetes prescriptions top 40 million, rising 50% in six years


Diabetes prescriptions in England have for the first time topped the 40 million level in year, a rise…


Lack of government funding in Brazil and Mexico holds back use off DPP-IV diabetes drugs


The majority of type 2 diabetes patients in Brazil and Mexico rely heavily or entirely on government-sponsored…

DiabetesHealthcareMarkets & MarketingPharmaceuticalSouth America

Novo Nordisk links with JDRF on type 1 diabetes R&D; type 2 study results


Danish insulin giant Novo Nordisk (NOV: N) is partnering with the US charitable organization JDRF to…

DiabetesHealthcareNovo NordiskPharmaceuticalResearch

Focus on the high cost of diabetes at OECD meeting


Across OECD countries some 83 million people suffer from diabetes and, on current trends, that will rise…


Women Rxed more medicines than men, but take less, US study finds


There is a wide gender divide when it comes to how men and women in the USA are prescribed and adhere…

Cardio-vascularDiabetesHealthcareNorth AmericaPharmaceutical



Back to top